Loading...
Docoh

FDMT
4D Molecular Therapeutics Inc
4DMT is a clinical-stage company harnessing the power of directed evolution for targeted gene therapies.
California
NASDAQ
AIM
AIM ImmunoTech Inc
AIM ImmunoTech Inc.
Florida
NYSE
AMGN
AMGEN Inc.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
California
NASDAQ
ARIA
ARIAD Pharmaceuticals Inc
ARIAD is a global oncology company focused on transforming the lives of cancer patients with breakthrough medicines.
Massachusetts
NASDAQ
ABCM
Abcam - ADR (Sponsored)
Abcam Plc distributes antibodies and associated protein research tools.
United Kingdom
NASDAQ
XLRN
Acceleron Pharma Inc
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.
Massachusetts
NASDAQ
ACHL
Achilles Therapeutics Plc
Achilles is a clinical-stage biopharmaceutical company developing precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell.
United Kingdom
NASDAQ
ACOR
Acorda Therapeutics Inc
Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders.
New York
NASDAQ
ABOS
Acumen Pharmaceuticals Inc
Acumen is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AβOs), which Acumen believes to be a key underlying cause of Alzheimer’s disease, or AD. Acumen is currently focused on advancing a targeted immunotherapy drug candidate, ACU193, to establish proof of mechanism in early AD patients.
Virginia
NASDAQ
ADAP
Adaptimmune Therapeutics Plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer.
United Kingdom
NASDAQ
ADPT
Adaptive Biotechnologies Corp
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Washington
NASDAQ
ADMA
Adma Biologics Inc
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
New Jersey
NASDAQ
APTCF
Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corp.
Massachusetts
OTC
ADVM
Adverum Biotechnologies Inc
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases.
California
NASDAQ
AERI
Aerie Pharmaceuticals Inc
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases.
North Carolina
NASDAQ
GNMX
Aevi Genomic Medicine, LLC
Aevi Genomic Medicine, Inc.
Pennsylvania
NASDAQ
AFTX
Affinia Therapeutics Inc.
Massachusetts
AGEN
Agenus Inc
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer.
Massachusetts
NASDAQ
Alan E Smith
Albert Erani